49 e-Letters

published between 2014 and 2017

  • Dissecting or dolichoectatic aneurysm?
    Paulo Puglia Jr

    To the editor,

    The interesting paper by Li et al. reports an important series of cases treated appropriately and carefully followed-up, but unfortunately the diagnosis may not be correct in all cases. Fusiform aneurysms appearing in angiograms may represent a variety of different histopathological pictures, including dissection, but also other types of aneurysms. A light to this question, quite recurrent in my p...

    Show More
  • Revisionist History
    Colin P. Derdeyn

    The reply from Perez et al to my letter of March 2012 is misleading and wrong in two important regards.1 First, they state that their report of the use of the solitaire stent for thrombectomy was just a case report, "nothing else". 2 This is not true. In fact, they explicitly use this report, both in the abstract and conclusion to lay claim for developing the stentreiever concept for thrombectomy: "This was the first...

    Show More
  • Authors' Response
    Charles Kerber

    As the first author (and the senior author) I am wholly responsible for any errors in the paper, including errors of attribution. I apologize first to our readers, and second to Dr. Altes, whose contributions are significant and are of continuing value.

    Charles Kerber M.D.

    Conflict of Interest:

    None declared

  • Reply to: ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy by Turk et al. Corrections of reported values of the STAR study.
    Vitor Mendes Pereira

    We read with interest the study published ADAPT FAST study article (Turk AS, et al.) as published first online in the Journal of NeuroInterventional Surgery on 25Feb2014. We would like to congratulate the authors for their work in improving aspiration technique for acute stroke treatment that have been quite disappointing on demonstrating improvement on clinical outcomes on previous publications (1, 2). The advent on th...

    Show More
  • Considerations of alteplase as an intra-arterial lytic agent
    John J Connors

    J. J. (Buddy) Connors MD, Interventional Neuroradiology, Vanderbilt University Medical Center, Nashville, TN.

    Re: Understanding IMS III: old data shed new light on a futile trial

    I read this article with great interest. The issue of tPA and its risk/benefit ratio for intra-arterial treatment of acute ischemic stroke is essential to understanding the results of IMS III. While possible toxic effects of...

    Show More
  • Susan C. Olenski

    Dr. Chen's article is an interesting change of format in Medical Journal articles. It is a "letter" presenting a unique perspective by addressing a young woman on the topic of philosophical and experiential aspects of his work as a neurosurgeon.

    This is a welcome addition to standard medical information. As a patient, intelligence and humanity are attributes I seek in a physician/surgeon. Dr. Chen's capacity...

    Show More
  • Letter to the Editor Regarding "Elderly patients with intracranial aneurysms have higher quality of life after coil embolization: a decision analysis"
    Ajay Malhotra

    Dear Editor: The study by Smith et al. is a valuable effort to look at outcomes in elderly patients with intracranial aneurysms.(1) However, we would like to raise a few questions about the study. The follow-up periods among the included studies are highly variable, which is a limitation that the authors acknowledged. The authors described in the Method section that a meta-regression was performed to measure the effects of...

    Show More
  • Response to Ready or not! Here comes ICD-10
    Joshua A. Hirsch

    In October 2011, JNIS published our article on the implementation of the ICD-10 codes1. The final line of the paper was..." The authors favor postponing implementation of ICD-10 and prefer a focus on core issues of improving care and access. The Centers for Medicare & Medicaid Services will require all health professionals and facilities to transition to ICD-10 by October 2013. ICD- 10 is viewed as being more nuanced...

    Show More
  • Pipeline, aneurysms and the FDA
    Joshua A. Hirsch

    Pipeline, aneurysms and the FDA

    Response to "Estimating the proportion of intracranial aneurysms likely to be amenable to treatment with the pipeline embolization device." J Neurointerv Surg. 2011 Dec 2. [Epub ahead of print]

    Ronil V. Chandra MBBS FRANZCR, Thabele M Leslie-Mazwi M.D and Joshua A Hirsch M.D

    Department of Interventional Neuroradiology/ Endovascular Neurosurgery Massachusetts Gen...

    Show More
  • Authors' Response
    David F. Kallmes

    We greatly appreciate the input by Dr. Chandra and colleagues. Our paper was a highly focused, empiric exercise to determine, based on morphology alone, the potential for endoluminal implants for treatment of aneurysms. There are myriad additional factors that, without question, will affect the appropriateness of such devices for a given aneurysm, including aneurysm rupture status, patient condition, age, tolerance of...

    Show More